Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTA for Serous Retinal Detachment in VKH Disease
NCT05031143Phase 3Completed
- Sponsor
- Benha University
- Start
- Apr 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in Vogt-Koyanagi-Harada disease (VKH), sponsored by Benha University. Started Apr 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
Vogt-Koyanagi-Harada disease (VKH)
Beyond the preview
Go deeper on NCT05031143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05031143.